Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Illumina, Inc.
  6. Summary
    ILMN   US4523271090

ILLUMINA, INC.

(ILMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/01/2021 12/02/2021 12/03/2021 12/06/2021 12/07/2021 Date
357.66(c) 357.48(c) 347.28(c) 351.65(c) 369.43 Last
1 142 372 1 090 650 1 148 479 1 211 856 1 246 805 Volume
-2.10% -0.05% -2.85% +1.26% +5.06% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4 424 M - -
Net income 2021 673 M - -
Net Debt 2021 225 M - -
P/E ratio 2021 80,3x
Yield 2021 -
Sales 2022 4 953 M - -
Net income 2022 522 M - -
Net cash position 2022 596 M - -
P/E ratio 2022 104x
Yield 2022 -
Capitalization 54 963 M 54 963 M -
EV / Sales 2021 12,5x
EV / Sales 2022 11,0x
Nbr of Employees 7 825
Free-Float 79,8%
More Financials
Company
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the... 
Read more
More about the company
Ratings of Illumina, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about ILLUMINA, INC.
02:41pFlagship Pioneering taps former FDA chief Hahn to head new cancer diagnostic firm
RE
12/06Illumina's Grail Subsidiary to Provide Early Cancer Detection Test For Alignment Health..
MT
12/03Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC, AMGN, ILMN, LL..
AQ
11/25Vitrolife To Distribute Genomic Testing Kits In Asia Pacific Region
MT
11/24INSIDER SELL : Illumina
MT
11/17Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
PR
11/17Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in ..
CI
11/16EU Expected to Raise Objections to Illumina's Completed $8 Billion Grail Purchase
MT
11/16INSIDER SELL : Illumina
MT
11/16Illumina, Genetic Alliance Launch $120 Million Program Expanding Genome Sequencing Acce..
MT
11/16Illumina defends Grail deal; expects EU formal objections on Wednesday
RE
11/16Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity ..
PR
11/08Baird Adjusts Illumina's Price Target to $437 From $493, Maintains Neutral Rating
MT
11/05INSIDER SELL : Illumina
MT
11/04Illumina Posts Higher Q3 Earnings, Revenue -- Stock Up
MT
More news
News in other languages on ILLUMINA, INC.
12/06La filiale Grail d'Illumina fournira un test de détection précoce du cancer aux membres..
11/25Vitrolife va distribuer des kits de test génomique dans la région Asie-Pacifique
11/16Illumina et Genetic Alliance lancent un programme de 120 millions de dollars pour élarg..
11/16Illumina défend l'accord Grail et s'attend à recevoir des objections formelles de l'UE ..
11/05VENTE D'INITIÉS : Illumina
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Analysis
Illumina : says it had expected EU hold order on Grail
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | MarketScreener
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 351,65 $
Average target price 441,73 $
Spread / Average Target 25,6%
EPS Revisions
Managers and Directors
Francis A. deSouza President, Chief Executive Officer & Director
Sam A. Samad Chief Financial Officer & Senior Vice President
John Wendell Thompson Chairman
Phillip G. Febbo Chief Medical Officer
Alex Aravanis CTO, Head-Research & Product Development
Sector and Competitors
1st jan.Capi. (M$)
ILLUMINA, INC.-6.14%54 963
THERMO FISHER SCIENTIFIC33.59%245 196
DANAHER CORPORATION38.16%219 304
INTUITIVE SURGICAL, INC.17.94%115 663
SIEMENS HEALTHINEERS AG51.93%80 663
EDWARDS LIFESCIENCES CORPORATION20.38%69 900